Topic 03 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 38 - 15 Topics

cite ad title authors publish year publish time dataset abstract mentions covid pmcid pubmed id doi cord uid topic weight Similarity scispacy Similarity specter
1 Jamieson_2016 Host resilience to emerging coronaviruses Jamieson, Amanda M 2016 2016-07-01 COMM-USE N PMC7079962 10.2217/fvl-2016-0060 m45lbfub 0.684578 Channappanavar_2017
2 Fears_2020 Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions Alyssa C Fears; William B Klimstra; Paul Duprex; Amy Hartman; Scott C. Weaver; Ken S. Plante; Divya Mirchandani; Jessica Plante; Patricia V. Aguilar; Diana Fernandez; Aysegul Nalca; Allison Totura; David Dyer; Brian Kearney; Matthew Lackemeyer; J. Kyle Bohannon; Reed Johnson; Robert F Garry; Doug S Reed; Chad J Roy 2020 2020-04-18 BioRxiv Y 10.1101/2020.04.13.20063784 zfm6xjkh 0.680362
3 Keum_2012 Development of chemical inhibitors of the SARS coronavirus: Viral helicase as a potential target Keum, Young-Sam; Jeong, Yong-Joo 2012 2012-11-15 PMC Y PMC7092843 22935448.0 10.1016/j.bcp.2012.08.012 hdw6bpnc 0.647938
4 Li_X_2020 Molecular immune pathogenesis and diagnosis of COVID-19 Li, Xiaowei; Geng, Manman; Peng, Yizhao; Meng, Liesu; Lu, Shemin 2020 2020-03-05 PMC Y 10.1016/j.jpha.2020.03.001 wl121lg4 0.620080
5 Chang_2016 Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein Chang, Chung-ke; Lo, Shou-Chen; Wang, Yong-Sheng; Hou, Ming-Hon 2016 2016-04-30 PMC N PMC7108309 26691874.0 10.1016/j.drudis.2015.11.015 3dezlekl 0.613452 Adedeji_2014
6 Graham_2013 A decade after SARS: Strategies to control emerging coronaviruses Graham, Rachel L.; Donaldson, Eric F.; Baric, Ralph S. 2013 2013-11-11 PMC Y PMC5147543 24217413.0 10.1038/nrmicro3143 9rugpout 0.595232 Adedeji_2014
7 Jenwitheesuk_2003 Identifying inhibitors of the SARS coronavirus proteinase Jenwitheesuk, Ekachai; Samudrala, Ram 2003 2003-11-17 PMC N PMC7119134 14592491.0 10.1016/j.bmcl.2003.08.066 9g3a0zas 0.576010
8 Wu_G_2004 Potential targets for anti-SARS drugs in the structural proteins from SARS related coronavirus Wu, Guang; Yan, Shaomin 2004 2004-06-30 PMC N PMC7124239 15203235.0 10.1016/j.peptides.2004.03.002 amzmyqys 0.559150
9 Adedeji_2014 Antiviral drugs specific for coronaviruses in preclinical development Adedeji, Adeyemi O; Sarafianos, Stefan G 2014 2014-10-31 None N PMC4195804 24997250.0 10.1016/j.coviro.2014.06.002 0j8rvapz 0.546259
10 Hilgenfeld_2013 From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses Hilgenfeld, Rolf; Peiris, Malik 2013 2013-10-31 PMC Y PMC7113673 24012996.0 10.1016/j.antiviral.2013.08.015 yev38f0k 0.499351
11 Gong_2018 The battle against SARS and MERS coronaviruses: Reservoirs and Animal Models Gong, Shu‐ran; Bao, Lin‐lin 2018 2018-07-28 NONCOMM N PMC6388065 30891557.0 10.1002/ame2.12017 zy8qjaai 0.432064
12 Milewska_2016 HTCC: Broad Range Inhibitor of Coronavirus Entry Milewska, Aleksandra; Kaminski, Kamil; Ciejka, Justyna; Kosowicz, Katarzyna; Zeglen, Slawomir; Wojarski, Jacek; Nowakowska, Maria; Szczubiałka, Krzysztof; Pyrc, Krzysztof 2016 2016-06-01 COMM-USE N PMC4889042 27249425.0 10.1371/journal.pone.0156552 gylxdjvi 0.414954 Pillaiyar_2020
13 Cinatl_Jr_2005 Role of interferons in the treatment of severe acute respiratory syndrome Cinatl Jr, Jindrich; Michaelis, Martin; Scholz, Martin; Doerr, Hans Wilhelm 2005 2005-02-23 PMC N PMC7103669 15174965.0 10.1517/14712598.4.6.827 kajs07ms 0.401483
14 Channappanavar_2014 T-cell-mediated immune response to respiratory coronaviruses Channappanavar, Rudragouda; Zhao, Jincun; Perlman, Stanley 2014 2014-05-21 PMC N PMC4125530 24845462.0 10.1007/s12026-014-8534-z nj1p4ehx 0.392150 Ng_O_2016
15 Martina_2005 Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitor Martina, Erika; Stiefl, Nikolaus; Degel, Björn; Schulz, Franziska; Breuning, Alexander; Schiller, Markus; Vicik, Radim; Baumann, Knut; Ziebuhr, John; Schirmeister, Tanja 2005 2005-12-15 PMC N PMC7127417 16216498.0 10.1016/j.bmcl.2005.09.012 lij14ztt 0.386583
16 Channappanavar_2017 Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology Channappanavar, Rudragouda; Perlman, Stanley 2017 2017-05-02 PMC N PMC7079893 28466096.0 10.1007/s00281-017-0629-x fymfqvp3 0.376725
17 Yin_Y_2017 MERS, SARS and other coronaviruses as causes of pneumonia Yin, Yudong; Wunderink, Richard G. 2017 2017-10-20 PMC N PMC7169239 29052924.0 10.1111/resp.13196 vuonolxg 0.373912 Pillaiyar_2020
18 Stein_2020 The 2019 coronavirus: Learning curves, lessons, and the weakest link Stein, Richard Albert 2020 2020-03-13 PMC Y PMC7165502 32052918.0 10.1111/ijcp.13488 qp13h0un 0.353174 Georgiev_2009
19 Ziebuhr_2004 Molecular biology of severe acute respiratory syndrome coronavirus Ziebuhr, John 2004 2004-08-31 PMC Y PMC7108451 15358261.0 10.1016/j.mib.2004.06.007 y64i8ui3 0.351507 Adedeji_2014, Tong_2006
20 Pillaiyar_2020 Recent discovery and development of inhibitors targeting coronaviruses Pillaiyar, Thanigaimalai; Meenakshisundaram, Sangeetha; Manickam, Manoj 2020 2020-01-30 PMC N 32006468.0 10.1016/j.drudis.2020.01.015 xxblr8qd 0.343132 Adedeji_2014
21 Grigoriev_2004 Mutational patterns correlate with genome organization in SARS and other coronaviruses Grigoriev, Andrei 2004 2004-03-31 PMC Y PMC7127256 15049309.0 10.1016/j.tig.2004.01.009 g68g6xxu 0.339240
22 Cinatl_2005 Development of antiviral therapy for severe acute respiratory syndrome Cinatl, Jindrich; Michaelis, Martin; Hoever, Gerold; Preiser, Wolfgang; Doerr, Hans Wilhelm 2005 2005-06-30 PMC N PMC7132397 15878786.0 10.1016/j.antiviral.2005.03.002 9ujofcsm 0.322082 Adedeji_2014
23 Hu_B_2015 Bat origin of human coronaviruses Hu, Ben; Ge, Xingyi; Wang, Lin-Fa; Shi, Zhengli 2015 2015-12-22 COMM-USE N PMC4687304 26689940.0 10.1186/s12985-015-0422-1 d2knbzhl 0.310121